Infectious Diseases in 2024: Polio Eradication, Pandemic Preparedness, and Climate Change Impacts
As we approach the fifth year of this decade, there is a cautious return to normalcy [...]
Fatal Flaw: The Tragic Case of Carlton Gautney and the Investigation into Medical Device Malfunctions
Carlton "PeeWee" Gautney Jr., a 59-year-old Alabama police dispatcher and diabetes patient, depended on a Medtronic [...]
Addressing the Opioid Crisis: The SUPPORT Act’s Bipartisan Effort in Congress
Major healthcare legislation is unlikely in an evenly divided Congress with looming elections. However, Congress is [...]
Advancements and Challenges in Real-World Data and Evidence in Healthcare
Real-world data (RWD) and real-world evidence (RWE) play significant roles in medical product development and regulatory [...]
Trinity Life Sciences Reports Promising Opportunities in China’s 2022 NRDL for Innovative Drugs
Trinity Life Sciences, a global life sciences solutions leader, reports promising opportunities for innovative drugs in [...]
CRISPR Therapeutics CMO Resigns Following Historic FDA Approval of Gene Therapy Casgevy
Six days after CRISPR Therapeutics received a significant FDA approval for its gene therapy Casgevy, developed [...]
New Government Roles to Investigate Healthcare Price-Gouging and Antitrust Issues in Biden Administration Initiative
The Biden administration is enhancing its scrutiny of healthcare price-gouging by creating new roles in three [...]
German Court Invalidates CureVac’s mRNA Vaccine Patent in Dispute with BioNTech, Impacting Stocks and Ongoing Litigations
Here's what you need to know: A German court ruled against CureVac in a patent dispute [...]
Accelerating Drug Development with AI and ML: Transforming the Future of Healthcare
The traditional drug development and approval process in the United States typically spans 10 to 12 [...]
Kaiser Permanente Awards Grants for AI and ML Research in Healthcare
The Kaiser Permanente Augmented Intelligence in Medicine and Healthcare Initiative (AIM-HI) Coordinating Center, part of the [...]
NIH Working Group Proposes Major Reforms for Postdoctoral Researchers Amid Rising Industry Losses
A National Institutes of Health (NIH) working group proposed significant changes to improve the conditions for [...]
FDA Approves Merck’s Welireg for Expanded Use in Kidney Cancer, Boosting Sales Prospects
Merck’s cancer drug Welireg (belzutifan), approved in August 2021, has been making steady sales progress. Recently, [...]
U.S. Health Spending Normalizes Post-Pandemic with a Decrease in GDP Share
The summary of the recent report on U.S. health spending is as follows: Annual Health Spending [...]
Challenges and Advancements in Rare Disease Research and Patient Care
The definition of a rare disease varies internationally. In the U.S., it's a condition affecting fewer [...]
Montana’s Slow Utilization of Opioid Settlement Funds Amid Rising Crisis
Nearly a year after Montana received millions of dollars from opioid settlement funds, a significant portion [...]
Supreme Court Revisits Abortion Pill Access and FDA’s Authority in Landmark Case
The Supreme Court has agreed to review the accessibility of mifepristone, a commonly used abortion pill, [...]
AstraZeneca Buys Icosavax for $838 Million to Boost Vaccine R&D and Compete in RSV Market
AstraZeneca is acquiring Icosavax for $838 million upfront, aiming to strengthen its vaccine research and development. [...]
ICER Report: Price Hikes for Eight Drugs Lead to $1.3 Billion Increase in U.S. Healthcare Costs
The Institute for Clinical and Economic Review (ICER) reported that price increases for eight drugs led [...]
Revolutionizing Healthcare: Epic and Elevance Health’s Data-Driven, AI-Enhanced Collaboration
The healthcare technology sector is experiencing significant advancements due to the efforts of two major players: [...]
FTC Challenges Sanofi’s Deal for Pompe Disease Treatment, Citing Monopoly Concerns
The Federal Trade Commission (FTC) is challenging Sanofi’s proposed $755 million deal to license Maze Therapeutics’ [...]
FDA Approves Groundbreaking CRISPR Gene-Editing Medicine for Sickle Cell Disease
The FDA has approved the world's first CRISPR gene-editing medicine, Casgevy, for sickle cell disease, marking [...]
Advancements and Challenges in GLP-1 Based Therapies for Diabetes and Obesity
In January 2010, the FDA approved Novo Nordisk's Victoza (liraglutide), a GLP-1 receptor agonist for Type [...]
Implementing Diversity Action Plans in Clinical Trials: Navigating FDA Requirements and Enhancing Inclusivity
In April 2022, the FDA mandated that all Phase 3 and pivotal studies include a Diversity [...]
Global Angiography Catheter Market: Surge in Demand Driven by Minimally Invasive Procedures and Cardiovascular Disease Prevalence
The global angiography catheter market, valued at $1.57 billion in 2024, is expected to grow at [...]
AbbVie Expands Neuroscience Portfolio with $8.7 Billion Acquisition of Cerevel Therapeutics
AbbVie has announced plans to acquire Cerevel Therapeutics, a neuroscience drugmaker, for $8.7 billion, marking its [...]